Sustained transdermal delivery of zidovudine via controlled release of penetration enhancer
- 30 September 1991
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 17 (1) , 41-47
- https://doi.org/10.1016/0168-3659(91)90129-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Enhanced transdermal derivery of zidovudine in rats and human skin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- Membrane permeation-controlled transdermal delivery system design. Influence of controlling membrane and adhesive on skin permeation of isosorbide dinitrate.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- Enhanced Delivery of Zidovudine Through Rat and Human Skin via Ester ProdrugsPharmaceutical Research, 1990
- Percutaneous absorption of azidothymidine in ratsInternational Journal of Pharmaceutics, 1989
- In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1989
- Utility of Topical Formulations of Morphine Hydrochloride Containing Azone and N-Methyl-2-pyrrolidoneSelective Cancer Therapeutics, 1989
- Basic studies on controlled transdermal delivery of nicardipine hydrochloride using ethylene-vinyl acetate and ethylene-vinyl alcohol copolymer membranes.CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
- Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseasesClinical Pharmacology & Therapeutics, 1987
- RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINEThe Lancet, 1987